Department of Medicine

Department of Medicine

  Division of Hematology/Oncology

[Return To Index page]
photo Annie Im, MD

Assistant Professor of Medicine, Division of Hematology/Oncology


Phone: 412-864-7764

Office: UPMC Cancer Pavilion, 5th Floor
5150 Centre Avenue
Pittsburgh, PA 15232
Phone: 412-864-7764
Administrative Assistant:
Janice Kizior
Address: 5150 Centre Avenue, 5th floor
Pittsburgh, PA 15232
Phone: 412-864-7764
Education and Training
MD, State University of New York Stony Brook School of Med, 2006
BA, Williams College, MA, 2001
Internal Medicine Residency, University of Pittsburgh Medical Center, 2009
Hematology/Oncology Fellowship, University of Pittsburgh Medical Center, 2013
Blood and Marrow Transplant Fellowship, University of Pittsburgh Medical Center, 2013
Research Interest
As a clinical researcher, she has been involved in the development of clinical trials for the treatment of acute myeloid leukemia (AML) and GVHD. Specifically, she has implemented a trial for the treatment of AML in elderly patients using a novel induction regimen based on the mechanism of epigenetic priming. In addition, she has an interest in novel targets for the treatment of chronic GVHD, such as JAK-STAT pathway inhibition, and has implemented trials in this area in collaboration with the Chronic GVHD Research Group in the Experimental Transplantation and Immunology Branch of the National Cancer Institute. Her clinical interests also include development of a Chronic GVHD and Long-Term Follow Up program for the stem cell transplant program at UPMC. Dr. Im has also been heavily involved in medical education for residents and fellows, serving as an Associate Program Director for the Hematology/Oncology Fellowship and the Subspecialty Education Coordinator for the Internal Medicine Residency from 2013-2016.
Clinical Interest
Dr. Im’s clinical focus is in hematologic malignancies and hematopoietic stem cell transplantation. Her current research interests are focused in the area of graft-versus-host disease (GVHD), a complication of stem cell transplant, as well as in late effects in transplant survivors.
For my complete bibliography, Click Here.
Selected Publications:
Im A, Mitchell SA, Steinberg SM, Curtis L, Berger A, Baird K, Kuzmina Z, Joe G, Comis LE, Juckett M, Avila D, Baruffaldi J, Masuch L, Pirsl F, Pavletic SZ. Prevalence and determinants of fatigue in patients with moderate to severe chronic graft-versus-host disease. Bone Marrow Transplant. Bone Marrow Transplant. 2016; 51(5): 705-12.
Im A, Raptis A, Hou J, Tompkins C, Winfield M, Guay M, Boyiadzis M, Agha M. Hypomethylating agents for relapse after allogeneic hematopoietic cell transplantation in myeloid malignancies: a case series and review of the literature. Acta Haematology. 2016; 135(4): 232-237.
Im A, Amjad A, Agha M, Raptis A, Hou JZ, Farah R, Lim S, Sehgal A, Dorritie KA, Redner FL, McLaughlin B, Shuai Y, Duggal S, Boyiadzis M. Mitoxantrone and Etoposide for the Treatment of Acute Myeloid Leukemia Patients in First Relapse. Oncology Research. 2016.
Im A, Pavletic SZ. Deciphering the Mystery: Extracorporeal Photopheresis in Graft-versus-Host Disease. Biology of Blood Marrow Transplant. 2015; 21(11): 1861-2.
Im A, Sehgal AR, Carroll MP, Smith BD, Johnson DE, Boyiadzis M. DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies. Leukemia. 2014; 28(9): 1774-83.
Im A, Appleman LJ. Mifepristone: pharmacology and clinical impact in reproductive medicine, endocrinology and oncology. Expert Opinion on Pharmacotherapy. 2010; 3: 481-8.
Taioli E, Im A, Xu X, Veenstra TD, Ahrendt G, Garte S. Comparisons of estrogens and estrogen metabolites in human breast tissue and urine. Reproductive Biology and Endocrinology. 2010; 96: 743-747.
Im A, Vogel VG, Ahrendt G, Lloyd S, Ragin C, Garte S, Taioli E. Urinary estrogen metabolites in women at high risk for breast cancer. Carcinogenesis. 2009; 9: 1532-5.
Notable Achievements
Selected for the ECOG-ACRIN Young Investigators Symposium, 2014